Hologic raises annual profit forecast on diagnostic and surgical demand
Hologic raised its profit forecast due to strong demand for diagnostics and surgical products.
View signal analysisHologic, Inc. · NASDAQ · Healthcare
Browse public HOLX signals with their source context and measured market impact. Open any signal for its permanent analysis page.
Hologic raised its profit forecast due to strong demand for diagnostics and surgical products.
View signal analysis →TPG and Blackstone bid over $16 billion for Hologic Inc. Hologic rejected the nonbinding offer but negotiations may resume. Proposed shares priced at $70 to $72, above closing price of $54.28. Hologic's stock dropped 24% this year due to tariffs and demand issues. Company lowered earnings guidance amid geopolitical challenges.
View signal analysis →Hologic lowered its fiscal 2025 profit forecast due to tariff uncertainties. The announcement caused a 3% drop in Hologic's shares.
View signal analysis →Hologic cuts fiscal 2025 revenue forecast due to declining breast health product sales. Shares dropped 5% post-announcement, indicating negative market reaction.
View signal analysis →Hologic acquires Gynesonics for $350 million to expand gynecological solutions. Acquisition enhances Hologic's minimally invasive surgical tool offerings for OB/GYNs. Hologic shares rose 1.5% to $81.03 following the acquisition news.
View signal analysis →Hologic acquires Gynesonics for $350 million to enhance women's health solutions. Gynesonics’ Sonata System offers incisionless treatment for uterine fibroids. Analysts expect Hologic to report $1.01 EPS with $977.05 million revenue. Synergy with existing products could enhance Hologic’s offering in women's health. Growth is expected despite cautious stance due to increased net interest expenses.
View signal analysis →